We are live on ! Find out more
RXDX

Prometheus Biosciences, Inc. Common Stock
RXDX

Delisted

RXDX was delisted on the 15th of June, 2023.

Back to rankings

2 hedge funds and large institutions have $1.98M invested in Prometheus Biosciences, Inc. Common Stock in 2023 Q2 according to their latest regulatory filings, with 0 funds opening new positions, 0 increasing their positions, 0 reducing their positions, and 216 closing their positions.

New
Increased
Maintained
Reduced
Closed

74% less call options, than puts

Call options by funds: $13.6M | Put options by funds: $51.5M

99% less funds holding

Funds holding: 219 → 2 (-217)

100% less capital invested

Capital invested by funds: $4.35B → $1.98M (-$4.35B)

100% less funds holding in top 10

Funds holding in top 10: 13 → 0 (-13)

100% less first-time investments, than exits

New positions opened: 0 | Existing positions closed: 216

Holders
2
Holders Change
-217
Holders Change %
-99.09%
% of All Funds
0.03%
Holding in Top 10
–
Holding in Top 10 Change
-13
Holding in Top 10 Change %
-100%
% of All Funds
–
New
–
Increased
–
Reduced
–
Closed
216
Calls
$13.6M
Puts
$51.5M
Net Calls
-$37.9M
Net Calls Change
-$118M

Top Buyers

No buyers this quarter

Top Sellers

Rank Fund Capital Flow
1
RI
RTW Investments
New York
-$351M
2
BlackRock
BlackRock
New York
-$300M
3
Vanguard Group
Vanguard Group
Pennsylvania
-$292M
4
BC
Boxer Capital
California
-$204M
5
7IH
72 Investment Holdings
Connecticut
-$198M
Name Holding Trade Value Shares
Change 		Change in
Stake
UBS AM
1
UBS AM
Illinois
$1.98M – – –
FCA
2
FinTrust Capital Advisors
South Carolina
$1.43K – – –
RI
3
RTW Investments
New York
– -$351M -3,272,104 Closed
BlackRock
4
BlackRock
New York
– -$300M -2,799,818 Closed
Vanguard Group
5
Vanguard Group
Pennsylvania
– -$292M -2,716,901 Closed
BC
6
Boxer Capital
California
– -$204M -1,897,500 Closed
7IH
7
72 Investment Holdings
Connecticut
– -$198M -1,848,024 Closed
CAM
8
Cormorant Asset Management
Massachusetts
– -$178M -1,655,000 Closed
Point72 Asset Management
9
Point72 Asset Management
Connecticut
– -$157M -1,465,420 Closed
FAM
10
Fred Alger Management
New York
– -$143M -1,331,759 Closed
PA
11
Perceptive Advisors
New York
– -$137M -1,272,694 Closed
State Street
12
State Street
Massachusetts
– -$133M -1,243,571 Closed
Fidelity Investments
13
Fidelity Investments
Massachusetts
– -$123M -1,146,049 Closed
FCM
14
Farallon Capital Management
California
– -$118M -1,100,806 Closed
RSCM
15
Rock Springs Capital Management
Maryland
– -$111M -1,031,550 Closed
CA
16
CHI Advisors
New York
– -$100M -934,135 Closed
T. Rowe Price Associates
17
T. Rowe Price Associates
Maryland
– -$95M -885,332 Closed
T. Rowe Price Investment Management
18
T. Rowe Price Investment Management
Maryland
– -$93.2M -868,006 Closed
D.E. Shaw & Co
19
D.E. Shaw & Co
New York
– -$85.6M -797,567 Closed
Westfield Capital Management
20
Westfield Capital Management
Massachusetts
– -$73.5M -684,694 Closed
Geode Capital Management
21
Geode Capital Management
Massachusetts
– -$73.2M -682,043 Closed
EAM
22
Eventide Asset Management
Massachusetts
– -$71.9M -670,020 Closed
Federated Hermes
23
Federated Hermes
Pennsylvania
– -$55.4M -516,589 Closed
Lord, Abbett & Co
24
Lord, Abbett & Co
New Jersey
– -$47.1M -439,098 Closed
Adage Capital Partners
25
Adage Capital Partners
Massachusetts
– -$45.2M -420,706 Closed
1
2 3 4 5

RXDX Hedge Fund Activity: Q2 2023 in Review

2 of the 6,369 institutional investors tracked by Wall St. Rank reported a position in Prometheus Biosciences, Inc. Common Stock (RXDX) for Q2 2023, worth a combined $1.98M — down 100% from $4.35B a quarter earlier.

Sellers outnumbered buyers: 216 funds closed out of RXDX and 0 opened new positions — a net loss of 216 holders — while 0 trimmed existing stakes and 0 added.

The largest seller was RTW Investments, exiting entirely with an estimated $351M sold.

  • 2 institutional investors held Prometheus Biosciences, Inc. Common Stock (RXDX) as of Q2 2023, down from 219 in Q1 2023.
  • Funds reported $1.98M of Prometheus Biosciences, Inc. Common Stock stock for Q2 2023, down 100% quarter-over-quarter.
  • 0 funds opened new Prometheus Biosciences, Inc. Common Stock positions in Q2 2023 and 216 closed out, a net change of -216 holders.
  • The largest Prometheus Biosciences, Inc. Common Stock seller in Q2 2023 was RTW Investments, an estimated $351M sold.

Based on aggregated 13F filings for Q2 2023.